MALAT1 and cancer: In addition, all these studies concerning miR-9 and MALAT-1 expressions were performed on various cancer cell lines or primary tumors obtained from patients with stage I–III NSCLC, including adenocarcinoma, squamous cell carcinoma, or other large cell carcinoma.